US$ 21.71
tirzepatide china Lilly plans $200M expansion in to make meds Tirzepatide | China | Manufacturer
Description
The combination of COX-1 & (at higher doses) COX-2 inhibition are the molecular basis for aspirin's analgesic, antipyretic & anti-inflammatory effects

While it is a glucagon-like peptide-1 (GLP-1) agonist, it also activates the glucose-dependent insulinotropic polypeptide (GIP) receptor

Draw 62.5 units

The results in mouse models were impressive

215866s000]
